N-(2,5-Dichlorophenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide

Catalog No. :
ACCOPF688
CAS No. :
335399-74-1
Molecular Formula :
C18H17Cl2N3O2S2
Molecular Weight :
442.39

IUPAC Name:N-(2,5-dichlorophenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide

N-(2,5-Dichlorophenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,5-Dichlorophenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
IUPAC NameN-(2,5-dichlorophenyl)-2-((3-ethyl-5,6-dimethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
MDL No.MFCD02741051
Molecular FormulaC18H17Cl2N3O2S2
Molecular Weight442.39
SMILESO=C(NC1=CC(Cl)=CC=C1Cl)CSC2=NC3=C(C(C)=C(C)S3)C(N2CC)=O
InChI KeyOSQMUGNLGHSDEL-UHFFFAOYSA-N
SynonymSALOR-INT L412937-1EA;N-(2,5-DICHLOROPHENYL)-2-[(3-ETHYL-5,6-DIMETHYL-4-OXO-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETAMIDE;Acetamide, N-(2,5-dichlorophenyl)-2-[(3-ethyl-3,4-dihydro-5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl)thio]-
CAS No.335399-74-1

Synthetic Route by SureRoute

1. ACCOPF688 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCOPF688 route product structure diagram
    ACCOPF688335399-74-1
Inquiry

2. ACCOPF688 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCOPF688 route product structure diagram
    ACCOPF688335399-74-1
Inquiry

Comments (0)